# Program 1 Phase C134 - D0 Findings Lifecycle Transition Decision Brief

Status: transition decision brief

## Decision

Move next to:

`Program 1 Phase D0 - Findings Lifecycle Foundation`

Do not implement an acknowledgment write endpoint as the next step.

## Why Acknowledgment Should Pause Here

The acknowledgment stack is now stable enough for:

- advisory context
- read-only review history
- denied-read access audit
- demo/pilot guardrail validation

It is not stable enough for:

- write endpoint exposure
- UI action workflow
- real patient data
- production use
- clinical enforcement

## Core Reason

A write acknowledgment endpoint can be misread as resolving clinical uncertainty.

ASTRA needs a Findings Lifecycle before a review action can be safely connected to unresolved clinical context.

## What Is A Finding

A finding is a source-linked clinical knowledge unit that may require human review, status tracking and lifecycle governance.

Examples may include:

- document-derived item needing review
- open clinical question
- readiness-relevant advisory signal
- source-linked limitation or warning

A finding is not automatically a task, diagnosis, clearance, approval or patient message.

## Why Findings Precede Enforcement

Findings provide the missing lifecycle layer between source-linked knowledge and workflow action.

Before enforcement or acknowledgment writes, ASTRA must define:

- finding identity
- source relationship
- review state
- status transitions
- human responsibility
- audit expectations
- no-go side effects

Without that layer, acknowledgment write behavior can drift into soft clearance.

## D0 Boundary

D0 should be documentation-only foundation.

D0 must not introduce:

- Task engine
- Outcome Evidence
- patient messaging
- production approval
- real-data approval
- clinical approval
- readiness clearance
- override workflow
- runtime enforcement

## Recommended Next Task

`Program 1 Phase D0 - Findings Lifecycle Foundation`

